Characteristic and Pregnancy Rate of IVF Patient: A Retrospective Analysis from Two Centres

Similar documents
Clinical Policy Committee

Infertility Causes, Prevention and Programmatic strategies

FREEDOM OF INFORMATION ACT 2000 Birmingham CrossCity CCG Ref: FOI/ IVF Funding Policy

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

Standardising Access Criteria to NHS Fertility Treatment FOR COMMISSIONERS OF FERTILITY SERVICES

Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

Fertility Facts and Figures 2008

The relevant NICE Clinical Guidance 156, Fertility can be accessed here:

it right? activity (page 4) to highlight ethical issues associated with IVF

Reproductive Technology. Chapter 21

Tower Hamlets CCG Fertility policy

Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

Assisted Conception Policy. February Dr. Liz Saunders Cyril Haessig

Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.

How to Find Out What s Wrong A BASIC GUIDE TO MALE. A doctor s guide for patients developed by the American Urological Association, Inc.

Malawi Population Data Sheet

Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc

OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

Illinois Insurance Facts Illinois Department of Insurance

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY

European IVF Monitoring (EIM) Year: 2008

University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

MALAWI YOUTH DATA SHEET 2014

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Assisted Reproductive Technologies at IGO

CHAPTER I INTRODUCTION. Here in the Philippines, we believe in the saying of our national hero Dr.

Topic: Male Factor Infertility

Promoting Family Planning

Lesbian Pregnancy: Donor Insemination

IVF SUCCESS RATES. Cancellation Rates. Under Age 35: 0% cancellations, national average 7.1% Age 35 37: 2.0% cancellations national average 10.

SOUTH AUSTRALIA REPRODUCTIVE TECHNOLOGY (CODE OF ETHICAL CLINICAL PRACTICE) REGULATIONS 1995

AUSTRALIA AND NEW ZEALAND FACTSHEET

Fast Track to IVF. Objectives

Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services.

Ethical issues in assisted reproductive technologies. Effy Vayena

Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006

Artificial insemination with donor sperm

NWL CSU IFR Team CLINICAL COMMISSIONING GROUP BRIEFING. UPDATE OF THE PPwT POLICY ON IN-VITRO FERTILISATION (IVF)

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART)

UF Health Jacksonville CHNA Implementation Strategy

Areas of Concern. Reproductive Ethics: Issues &

Pregnancy Intendedness

Understanding Fertility

European IVF Monitoring (EIM) Year: 2010

Delaying First Pregnancy

Statement by Dr. Sugiri Syarief, MPA

Parentage, Adoption, and Child Custody

Male Infertility. Penis. Epididymis

Crohn's disease and pregnancy.

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)

Getting Pregnant: The Natural Approach Revealing the Secrets to Increase Your Fertility

Preventive Services for Pregnancy SERVICE WHAT IS COVERED INTERVALS OF COVERAGE Anemia Screening Screening Annual screening for pregnant women

Important health care reform notice Women s preventive services covered with no member cost share

HIV and AIDS in Bangladesh

Causes for unintentional childlessness

Disclosure. Objectives 2/21/2016

IVF Waiting Times in Scotland

Medical termination of pregnancy and subsequent adoption of contraception

MECHANISM OF ACTION. Fertility Awareness-Based Methods. Victoria H. Jennings, PhD Marcos Arevalo, MD, MPH Deborah Kowal, MA, PA

Progress and prospects

Patient Information: Endometriosis Disease Process and Treatment

Male Infertility and Intracytoplasmic Sperm Injection (ICSI) in the Middle East

How To Get A Refund On An Ivf Cycle

Facts and Figures on Sexual Behaviour and Teenage Pregnancy (2)

Internship at the Centers for Diseases Control

HIV/AIDS AND OTHER SEXUALLY TRANSMITTED INFECTIONS 11

Group Insurance Plan of Benefits for New York University (Control # ) administered by Aetna International Effective Date: January 1, 2016

Gestational Surrogacy in Maryland Alive and Well after Roberto d.b

BUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE

Pakistan Demographic and Health Survey

Federal Act on Medically Assisted Reproduction

Ehlers-Danlos Syndrome Fertility Issues. Objectives

Recommended Ethical Principles. Regarding the Use of Assisted Reproduction. in HIV Infected Individuals

When a Child Dies. A Survey of Bereaved Parents. Conducted by NFO Research, Inc. on Behalf of. The Compassionate Friends, Inc.

in vitro Fertilization (IVF)

Frequently Asked Questions (FAQs)

Egg and sperm donation in the UK:

HIV/AIDS: AWARENESS AND BEHAVIOUR

Population, Health, and Human Well-Being-- Benin

Assisted reproductive technology in Australia and New Zealand 2010

METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN (651)

The Importance of Mental Health and Gender in Taiwan

World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health

FATHERS. Professor Lorraine Sherr Royal Free and UC Medical School London UK

abortion your questions answered

Mid-year population estimates. Embargoed until: 20 July :30

Turkey. HDI values and rank changes in the 2013 Human Development Report

Related TeensHealth Links

Child Marriage and Education: A Major Challenge Minh Cong Nguyen and Quentin Wodon i

Adolescent Pregnancy and Parenting

Trends in Male Reproductive Health

M I L L I O N S Figure 2.1 Number of people newly infected with HIV

ASSISTED REPRODUCTIVE TECHNOLOGY Adopted 2013

Transcription:

The 6th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2016), Volume 2016 Conference Paper Characteristic and Pregnancy Rate of IVF Patient: A Retrospective Analysis from Two Centres Linda Lestari, Gita Pratama, Mila Maidarti, Achmad K. Harzif, and Budi Wiweko Division of Reproductive Endocrinology and Infertility, Department of Obstetric and Gynaecology, Faculty of Medicine, Universities Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia Corresponding Author: Hang Li; email: Huangli@gmail.com Received: 24 August 2016 Accepted: 25 September 2016 Published: 4 October 2016 Publishing services provided by Knowledge E Linda Lestari et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. Selection and Peer-review under the responsibility of the ASPIRE Conference Committee. Abstract Introduction. According to recent statistics, infertility in Indonesia reached 21,9%. In-vitro fertilization (IVF) was a reliable treatment option for subfertility couples with success rate of 22-40%. Data from the Indonesia Association for In-Vitro Fertilization (Perfitri) in 2010 showed the country had only 2000 cases, one third of Vietnam s and half of Thailand s. The technology s high cost has been cited as the cause behind the slow development of IVF in Indonesia. Objective. We aim to evaluate the characteristics of patients and their pregnancy rate following in vitro fertilization in infertile couples from two different centres, Yasmin Clinic and Kedoya Clinic. Material and Methods. Cohort retrospective was used to analyse outpatient data from two fertility centres. A total of 510 outpatients data, 405 in Yasmin Clinic and 105 in Kedoya Clinic, between October 2014 to September 2015 was collected. Patients and in vitro fertilization cycle characteristics from both clinics were evaluated. The pregnancy rate after IVF was compared between the groups. Result. Although maternal age (p=0,032) and paternal age (p=0,017) were statistically significant, they were not clinically significant. There were also no significant differences in the characteristics of in vitro fertilization in both clinics, clinically. However, pregnancy rate was higher in Yasmin Clinic than in Kedoya Clinic, with pregnancy rate of 64,8% and 45,7%, respectively (OR = 2,185; 95%CI 1,420-3,361; p=0,001). Discussion. There were no differences between characteristics of patients and in vitro fertilization cycle in both centres. Nevertheless, pregnancy rate between Yasmin Clinic and Kedoya Clinic were statistically different, suggesting another factors that influence success rate of in vitro fertilization. This research showed that most patients seek medical attention at the age of 35, after 7 years of infertility, suggesting awareness of infertility problem is still low. Keywords: infertility, in-vitro fertilization, cost 1. Introduction According to World Health Organization (WHO), infertility is a reproduction system disease characterized by failure to achieve a clinical pregnancy after 12 month or more of regular unprotected sexual intercourse. Primary infertility for women is defined by inability to ever bear a child, which can be caused by inability to become pregnant or inability to carry a pregnancy to a live birth. Secondary infertility is when a woman How to cite this article: Linda Lestari, Gita Pratama, Mila Maidarti, Achmad K. Harzif, and Budi Wiweko, (2016) Characteristic and Pregnancy Rate of IVF Patient: A Retrospective Analysis from Two Centres, in, The 6th Congress of the Asia Pacific Initiative on Reproduction, KnE Medicine, pages 43 48. DOI 10.18502/kme.v1i1.535 Page 43

is unable to bear a child after a previous pregnancy or a previous ability to carry a pregnancy to a live birth [1]. In 2010, 1,9% of 20-44 years old women who seek for a child were unable to attain pregnancy or have a live birth (primary infertility), and 10,5% child-seeking women were unable to have an additional child (secondary infertility). Worldwide, the estimated number of 48,5 million couples are unable to have a child, 21,5 million of which are having primary infertility and the rest are secondary infertility. In the United States, about 6% of married women in reproductive age (15-44 years old) are unable to conceive after a year of regular unprotected sex, and 12% of women 15-44 years old regardless of marital status have difficulty to get pregnant or carry a live birth [2,3]. In Indonesia, according to Riset Kesehatan Dasar (RISKESDAS) 2010, about 5,5-5,9% of married women aged more than 40 years old had not had a living child (primary infertility). This number was even higher in married women aged 20-39, this number varied with the highest was 21,9% [4]. Infertility is not only women s problems; it can be caused by the male factor. Male factor is responsible in 40% of couples and the female factor is responsible in 40% of couples. The remainder of infertility cases are either male and female factors combined or unexplained infertility, meaning a clear cause is not identified [5]. Aging is the most common risk factors in infertility, especially among females. Sexually transmitted diseases such as chlamydia and gonorrhea infection is associated with pelvic inflammatory disease, which is a frequent cause for tubal factor infertility. Overweight and obesity in women also associated with ovulatory dysfunction. The most common male factor for infertility is idiopathic, but trauma, infection, varicocele, and exposure to environmental toxin may affect semen production. Smoking in both men and women is also a factor that impairs fertility [5]. With the development of technology, more advanced treatments for infertility are now available. Infertility can be treated by medication, intrauterine insemination or artificial insemination, and assisted reproductive therapy, including in-vitro fertilization. IVF success rate in United States were quite high, 40% in women younger than 35 years of age, 31% in women aged 35-37 years, 22% in women aged 38-40 years, 12% in women aged 41-42 years, 4% in 43-44 years and 2% in women aged 44 years and older. This number varies from clinic to clinic and also depends on infertility diagnoses [3]. Despite the availability of infertility treatments, in Indonesia, in-vitro fertilization technique is still not widely used. Based on Indonesia Association for In-Vitro Fertilization (Perfitri) data, in 2010, there were only 2000 cases of in-vitro fertilization in Indonesia, which was only one third of Vietnam s and half of Thailand s. One of the reasons behind this was the service s fee is high, so that low and middle-income family cannot afford it. However, the service s fee varies between clinics. Therefore, new couples with limited budget who have longed for a child could choose cheaper, more affordable clinics if they choose to go for in-vitro fertilization. We conducted an observational study in two in-vitro fertilization centers in Jakarta. Yasmin Clinic, under Cipto Mangunkusumo General Hospital, offers in-vitro fertilization service with high cost. The other center was Kedoya Clinic, which also offers in-vitro DOI 10.18502/kme.v1i1.535 Page 44

fertilization therapy for lower price. One cycle of in-vitro fertilization in Yasmin Clinic costs 50-70 million rupiahs, depends on initial assessment result and drug used, while in Kedoya Clinic, a cycle of in-vitro fertilization costs 35 million rupiahs. Our primary objective was to evaluate the characteristics of patients and their pregnancy rate following in vitro fertilization in infertile couples who underwent in-vitro fertilization program in these clinics. 2. Methods 2.1. Population and Sample This is an observational analytic study using retrospective cohort approach. Target population of this research was all infertile couples who underwent in-vitro fertilization treatment. The accessible population was couples who did in-vitro fertilization in Yasmin Clinic (RSCM) and Kedoya Clinic. We used consecutive sampling method to choose the sample used in this study. 2.2. Data Collection Data from medical record of patients in those two in-vitro fertilization center in Jakarta were collected. All medical records which fulfilled inclusion and exclusion criteria were included in this study. Inclusion criteria used in this research are all infertile couples who opted in-vitro fertilization treatment in Yasmin Clinic or Kedoya Clinic, and who completed the intervention. Data excluded from this study are the ones with incomplete or loss of medical record data. All medical records from Yasmin Clinic and Kedoya Clinic between October 2014 to September 2015 were collected. From all the collected medical records, 510 met the inclusion and exclusion criteria, 405 of which was from Yasmin Clinic and 105 was from Kedoya Clinic. Indicators used to compare patient s characteristics were maternal age, maternal weight, period of infertility, and paternal age. In-vitro fertilization cycle characteristics were compared using total of in-vitro fertilization trials, number of oocytes, number of inseminated oocytes, embryo produced, fertility rate, cleavage, and cleavage rate. Pregnancy rate in both clinics was assessed with biochemical test after in-vitro fertilization trials. 2.3. Data Analysis Obtained data then analyzed using Statistical Package for the Social Sciences (SPSS) for Windows version 11.0 software. Statistical analysis used in this paper was Mann- Whitney to compare the characteristics of patients and characteristics of in-vitro fertilization cycle between the centers. Chi-square was used to compare the pregnancy rate between the two clinics based on the biochemical test. DOI 10.18502/kme.v1i1.535 Page 45

Yasmin Kedoya p n Median (min-max) n Median (min-max) Maternal age (years) 405 35,0 (21,0-48,0) 104 34,0 (21,0-42,0) 0,032 Maternal weight (kg) 152 59,0 (36,5-87,0) 58 59,8 (43,0-100,0) 0,326 Infertility duration 148 7,0 (1,0-20,0) 58 7,0 (1,0-15,0) 0,227 (years) Paternal age (years) 44 36,0 (28,0-52,0) 102 39,0 (28,0-59,0) 0,017 T 1: Demographic characteristics of patients. Yasmin Kedoya p n Median (min-max) n Median (min-max) Number of IVF trials 137 1,0 (1,0-4,0) 68 1,0 (1,0-2,0) 0,004 Number of oocytes 450 9,0 (1,0-1.500.000,0) 105 9,0 (0,0-36,0) 0,114 Inseminated oocytes 450 7,5 (1,0-37,0) 105 8,0 (1,0-33,0) 0,344 Embryo produced 450 5,0 (1,0-26,0) 105 5,0 (1,0-26,0) 0,054 Fertility rate (%) 450 66,67 (14,29-100,00) 105 73,05 (22,22-100,00) 0,014 Cleavage 450 5,0 (1,0-26,0) 105 5,0 (0,0-24,0) 0,098 Cleavage rate (%) 450 100,0 (10,0-100,0) 105 100,0 (60,0-100,0) <0,001 T 2: In-vitro fertilization cycle characteristics. 3. Result From October 2014 to September 2015, there were 510 complete medical record data which contained biochemical pregnancy. These medical records, 405 data from patients in Yasmin Clinic and 105 data from patients in Kedoya Clinic, were included in the analysis. Data from both clinics showed that there were neither clinical nor statistical difference in maternal weight and infertility duration (Table 1). Even though there were significant statistical difference in paternal and maternal age, there were no clinical difference based on the median. No statistical difference may be caused by large sample size. Overall, there were no significant difference between patients characteristics in Yasmin Clinic and Kedoya Clinic. Table 2 showed that there were no significant differences in almost all variables of in-vitro fertilization cycle characteristics. Although total of in-vitro fertilization trials and cleavage rate were statistically significant, they were not clinically significant. Mean difference between number of in-vitro fertilization trials was only 0,22 ± 0,058, and only 1,11 ± 0,840% for cleavage rate. Thus, there were also no significant differences between the two clinics in in-vitro fertilization cycle characteristics. While patients characteristics in both clinics were similar, the pregnancy rate in Yasmin Clinic was significantly higher than in Kedoya Clinic, accounted for 64,8% in Yasmin Clinic and 45,7% in Kedoya Clinic (OR = 2,185; 95%CI 1,420-3,361; p=0,001). DOI 10.18502/kme.v1i1.535 Page 46

Biochemical Pregnancy p Yes No N % n % Location Yasmin 287 64,8 156 35,2 0,001 Kedoya 48 45,7 57 54,3 Total 335 61,1 213 38,9 T 3: Pregnancy rate of Yasmin Clinic and Kedoya Clinic based on biochemical pregnancy. 4. Discussion Our research shows that there are no characteristic differences in patients of Yasmin Clinic and Kedoya Clinic, in spite of price difference. We expected to see younger patients in Kedoya Clinic as it is cheaper than Yasmin Clinic, but the median showed no age difference in patients of both centers. The reason might be the stigma in community that in-vitro fertilization technique is expensive. Another reason might be that although Kedoya Clinic is cheaper than Yasmin Clinic, the fee is still unaffordable for low- and middle-income family in Indonesia. Median value of maternal age in both clinics is 34-35 years. Pregnancy in women aged 35 years and older fall into advanced maternal age (AMA) category. Advanced maternal age increases the failure of IVF treatment, risk of maternal near miss, maternal death and severe maternal outcome compared to pregnancy in women aged 20-34 years. It also increases the risk of preterm birth, low birthweight, NICU admission, and birth asphyxia [6]. This finding suggests that the awareness of advanced maternal age is still low, thus selling infertility problem short. Further research may be needed to evaluate maternal educational level towards infertility and advanced maternal age, and education should be given to all young couples about infertility. Young couples should be informed to seek medical attention if they cannot get pregnant after 6 months of regular unprotected intercourse in their early 30s to have a safer, healthier pregnancy. Despite patients similar characteristics, pregnancy rate in Yasmin Clinic is significantly higher than in Kedoya Clinic. The pregnancy rate difference implies that there are another factors which are not included in this study, may be patients compliance, or technical issues such as different in-vitro fertilization technique, different medium used to transfer the embryo, quality of reagents, or technician s skill. It seems that higher cost also increases the effectivity and quality of in-vitro fertilization program, yet another study should be conducted to evaluate these factors. 5. Conclusion There are no differences in patients characteristics in Yasmin Clinic (high cost) and Kedoya Clinic (lower cost), which may be caused by the price is still too high for the society. However, the pregnancy rate is significantly higher in Yasmin Clinic and Kedoya Clinic, suggesting high cost increases the quality of treatment. DOI 10.18502/kme.v1i1.535 Page 47

Acknowledgments Authors would like to thank our mentor, Dr. dr. Budi Wiweko, SpOG(K) for his expertise which guided us in doing this study, helping and supporting us in many ways while making this paper. This research also made possible with cooperation of Yasmin Clinic and Kedoya Clinic for letting us do the research there. We also would like to express our gratitude to all related parties we cannot name one by one, who have encouraged us, gave us insights while doing this research. References [1] World Health Organization. Infertility definition and terminology [Internet]. No date [cited 2016 Mar 4]. Available from: http://www.who.int/reproductivehealth/ topics/infertility/definitions/en/. [2] M. N. Mascarenhas, S. R. Flaxman, T. Boerma, S. Vanderpoel, and G. A. Stevens, National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys, PLoS Medicine, 9, no. 12, Article ID e1001356, (2012). [3] Centers for Disease Control and Prevention. Infertility FAQs [Internet]. 2015 Sept 16 [cited 2016 Mar 4]. Available from: http://www.cdc.gov/reproductivehealth/ infertility/. [4] Indonesian Republic. Riset kesehatan dasar 2010. Jakarta: Ministry of Health; 2010. [5] F. F. Ferri, Ferris clinical advisor, 701 702e, Elsevier, California, 2016. [6] M. Laopaiboon, P. Lumbiganon, N. Intarut, R. Mori, T. Ganchimeg, J. P. Vogel, J. P. Souza, A. M. Gülmezoglu, and, Advanced maternal age and pregnancy outcomes: a multicountry assessment., BJOG: an international journal of obstetrics and gynaecology, 121, 49 56, (2014). DOI 10.18502/kme.v1i1.535 Page 48